Artal Group
Latest statistics and disclosures from Artal Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CAVA, LXRX, and represent 100.00% of Artal Group's stock portfolio.
- Reduced shares in these 10 stocks: CAVA (-$743M), ARWR (-$109M), SRRK (-$94M), KYMR (-$90M), MORF (-$86M), LXRX (-$61M), APLS (-$56M), DYN (-$54M), SLN (-$53M), SWTX (-$50M).
- Sold out of its positions in SLRN, ACHL, ADBE, AVTE, AGEN, ALVR, GOOGL, ANRO, AMZN, APLS.
- Artal Group was a net seller of stock by $-2.3B.
- Artal Group has $2.4B in assets under management (AUM), dropping by -39.27%.
- Central Index Key (CIK): 0001053906
Tip: Access up to 7 years of quarterly data
Positions held by Artal Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Artal Group
Artal Group holds 2 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cava Group Ord (CAVA) | 91.0 | $2.2B | -25% | 18M | 123.85 |
|
| Lexicon Pharmaceuticals Com New (LXRX) | 9.0 | $214M | -22% | 136M | 1.57 |
|
Past Filings by Artal Group
SEC 13F filings are viewable for Artal Group going back to 2012
- Artal Group 2024 Q3 filed Nov. 13, 2024
- Artal Group 2024 Q2 filed Aug. 14, 2024
- Artal Group 2024 Q1 restated filed May 17, 2024
- Artal Group 2024 Q1 filed May 13, 2024
- Artal Group 2023 Q4 filed Feb. 9, 2024
- Artal Group 2023 Q3 filed Nov. 13, 2023
- Artal Group 2023 Q2 filed Aug. 11, 2023
- Artal Group 2023 Q1 filed May 12, 2023
- Artal Group 2022 Q4 filed Feb. 13, 2023
- Artal Group 2022 Q3 filed Nov. 14, 2022
- Artal Group 2022 Q2 filed Aug. 11, 2022
- Artal Group 2022 Q1 filed May 12, 2022
- Artal Group 2021 Q4 filed Feb. 11, 2022
- Artal Group 2021 Q3 filed Nov. 12, 2021
- Artal Group 2021 Q2 filed Aug. 13, 2021
- Artal Group 2021 Q1 filed May 14, 2021